Cost-effectiveness of a National Telemedicine Diabetic Retinopathy Screening Program in Singapore

Ophthalmology

Volumn 123, Issue 12, 2016, Pages 2571-2580

  Nguyen, Hai V ^a   Tan, Gavin Siew Wei ^b   Tapp, Robyn Jennifer ^c,d   Mital, Shweta ^e   Ting, Daniel Shu Wei ^b   Wong, Hon Tym ^f   Tan, Colin S ^f   Laude, Augustinus ^f   Tai, E Shyong ^g   Tan, Ngiap Chuan ^h   Finkelstein, Eric A ^e   Wong, Tien Yin ^b,i   Lamoureux, Ecosse L ^b,i  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d LEEDS METROPOLITAN UNIVERSITY   (United Kingdom)

^e DUKE NUS MEDICAL SCHOOL   (Singapore)

^f TAN TOCK SENG HOSPITAL   (Singapore)

^g Dept Medicine Endocrinol Diabet   (Singapore)

^h SINGHEALTH POLYCLINICS   (Singapore)

ⁱ Academy of Medicine Singapore   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DIABETIC PATIENT; DIABETIC RETINOPATHY; GENERAL PRACTITIONER; HEALTH CARE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SCREENING; SINGAPORE; TELEMEDICINE; COMPLICATION; COST BENEFIT ANALYSIS; ECONOMICS; EPIDEMIOLOGY; FEMALE; MALE; MARKOV CHAIN; MASS SCREENING; PUBLIC HEALTH;

COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MARKOV CHAINS; MASS SCREENING; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; QUALITY-ADJUSTED LIFE YEARS; SINGAPORE; TELEMEDICINE;

EID: 84992365152     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2016.08.021     Document Type: Article

References (41)

1. 1 Yau, J.W., Rogers, S.L., Kawasaki, R., et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35 (2012), 556–564.
2. 2 Ting, D.S.W., Cheung, G.C.M., Wong, T.Y., Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Experiment Ophthalmol 44 (2016), 260–277.
3. 3 Klein, B.E., Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol 14 (2007), 179–183.
4. 4 Cheung, N., Mitchell, P., Wong, T.Y., Diabetic retinopathy. Lancet 376 (2010), 124–136.
5. 5 International Diabetes Federation, International Diabetes Atlas. Key Findings. 6th ed, 2014 Available at: www.idf.org/diabetesatlas/update-2014; Accessed June 2015.
6. 6 Chan, J.C., Malik, V., Jia, W., et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 301 (2009), 2129–2140.
7. 7 International Council of Ophthalmology, ICO Guidelines for Diabetic Eye Care. 2014 Available at: http://www.icoph.org/downloads/ICOGuidelinesforDiabeticEyeCare.pdf; Accessed March 1, 2016.
8. 8 The Royal College of Ophthalmologists, Diabetic Retinopathy Guidelines. 2012 Available at: https://www.rcophth.ac.uk/wp-content/uploads/2014/12/2013-SCI-301-FINAL-DR-GUIDELINES-DEC-2012-updated-July-2013.pdf; Accessed March 1, 2016.
9. 9 Silva, P.S., Aiello, L.P., Telemedicine and eye examinations for diabetic retinopathy: a time to maximize real-world outcomes. JAMA Ophthalmol 133 (2015), 525–526.
10. 10 Lin, D.Y., Blumenkranz, M.S., Brothers, R.J., et al. The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography. Am J Ophthalmol 134 (2002), 204–213.
11. 11 Massin, P., Erginay, A., Ben Mehidi, A., et al. Evaluation of a new non-mydriatic digital camera for detection of diabetic retinopathy. Diabet Med 20 (2003), 635–641.
12. 12 Bragge, P., Gruen, R.L., Chau, M., et al. Screening for presence or absence of diabetic retinopathy: a meta-analysis. Arch Ophthalmol 129 (2011), 435–444.
13. 13 Mansberger, S.L., Sheppler, C., Barker, G., et al. Long-term comparative effectiveness of telemedicine in providing diabetic retinopathy screening examinations: a randomized clinical trial. JAMA Ophthalmol 133 (2015), 518–525.
14. 14 Tapp, R.J., Svoboda, J., Fredericks, B., et al. Retinal photography screening programs to prevent vision loss from diabetic retinopathy in rural and urban Australia: a review. Ophthalmic Epidemiol 22 (2014), 52–59.
15. 15 Nathoo, N., Ng, M., Rudnisky, C.J., Tennant, M.T., The prevalence of diabetic retinopathy as identified by teleophthalmology in rural Alberta. Can J Ophthalmol 45 (2010), 28–32.
16. 16 Arora, S., Kurji, A.K., Tennant, M.T., Dismantling sociocultural barriers to eye care with tele-ophthalmology: lessons from an Alberta Cree community. Clin Invest Med 36 (2013), 57–63.
17. 17 Hartnett, M.E., Key, I.J., Loyacano, N.M., et al. Perceived barriers to diabetic eye care: qualitative study of patients and physicians. Arch Ophthalmol 123 (2005), 387–391.
18. 18 Aoki, N., Dunn, K., Fukui, T., et al. Cost-effectiveness analysis of telemedicine to evaluate diabetic retinopathy in a prison population. Diabetes Care 27 (2004), 1095–1101.
19. 19 Whited, J.D., Datta, S.K., Aiello, L.M., et al. A modeled economic analysis of a digital teleophthalmology system as used by three federal healthcare agencies for detecting proliferative diabetic retinopathy. Telemed J E Health 11 (2005), 641–651.
20. 20 Rachapelle, S., Legood, R., Alavi, Y., et al. The cost–utility of telemedicine to screen for diabetic retinopathy in India. Ophthalmology 120 (2013), 566–573.
21. 21 Rein, D.B., Wittenborn, J.S., Zhang, X., et al. The cost-effectiveness of three screening alternatives for people with diabetes with no or early diabetic retinopathy. Health Serv Res 46 (2011), 1534–1561.
22. 22 Coronado, A.C., Zaric, G.S., Martin, J., et al. Diabetic retinopathy screening with pharmacy-based teleophthalmology in a semiurban setting: a cost-effectiveness analysis. CMAJ Open, 4, 2016, E95.
23. 23 Brady, C.J., Villanti, A.C., Gupta, O.P., et al. Tele-ophthalmology screening for proliferative diabetic retinopathy in urban primary care offices: an economic analysis. Ophthalmic Surg Lasers Imaging Retina, 45, 2014, 556.
24. 24 Chiang, P.P., Lamoureux, E.L., Cheung, C.Y., et al. Racial differences in the prevalence of diabetes but not diabetic retinopathy in a multi-ethnic Asian population. Invest Ophthalmol Vis Sci 52 (2011), 7586–7592.
25. 25 Bhargava, M., Cheung, C.Y., Sabanayagam, C., et al. Accuracy of diabetic retinopathy screening by trained non-physician graders using non-mydriatic fundus camera. Singapore Med J 53 (2012), 715–719.
26. 26 The Diabetic Retinopathy Study Group. Report No 7. A modification of the Airlie House classification of diabetic retinopathy. Invest Ophthalmol Vis Sci 21 (1981), 211–226.
27. 27 Wu, L., Fernandez-Loaiza, P., Sauma, J., et al. Classification of diabetic retinopathy and diabetic macular edema. World J Diabetes 4 (2013), 290–294.
28. 28 Ministry of Health, National Health Survey 2010. 2011 Available at: www.moh.gov.sg/content/dam/moh_web/Publications/Reports/2011/NHS2010%20-%20low%20res.pdf; Acessed: September 13, 2016.
29. 29 Wong, T.Y., Cheung, N., Tay, W.T., et al. Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology 115 (2008), 1869–1875.
30. 30 Zheng, Y., Lamoureux, E.L., Lavanya, R., et al. Prevalence and risk factors of diabetic retinopathy in migrant Indians in an urbanized society in Asia: the Singapore Indian Eye Study. Ophthalmology 119 (2012), 2119–2124.
31. 31 Javitt, J.C., Aiello, L.P., Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med 124:1 Pt 2 (1996), 164–169.
32. 32 Tung, T.H., Chen, S.J., Shih, H.C., et al. Assessing the natural course of diabetic retinopathy: a population-based study in Kinmen, Taiwan. Ophthalmic Epidemiol 13:5 (2006), 327–333.
33. 33 Peng, C.-C., Chou, P., Tung, T.-H., et al. Cost-benefit analysis of screening for diabetic retinopathy among Chinese type 2 diabetes: decision from different perspectives of a population-based study. Health, 1(4), 2009, 304.
34. 34 Department of Statistics Singapore. Complete Life Tables 2013 for Singapore Resident Population. Available at: http://www.singstat.gov.sg/publications/publications-and-papers/population.
35. 35 Neumann, P.J., Costing and perspective in published cost-effectiveness analysis. Med Care 47:7 Suppl 1 (2009), S28–S32.
36. 36 Ministry of Manpower, Singapore Workforce. 2015 Available at: http://stats.mom.gov.sg/iMAS_PdfLibrary/mrsd-singapore-workforce-2015.pdf#page=7; Accessed December 9, 2015.
37. 37 Department of Statistics Singapore. Singapore Residents By Age Group, Ethnic Group and Sex, End June, Annual 2015. Available at: http://www.tablebuilder.singstat.gov.sg/publicfacing/createDataTable.action?refId=315. Accessed September 13, 2016.
38. 38 Smith, D.H., Johnson, E.S., Russell, A., et al. Lower visual acuity predicts worse utility values among patients with type 2 diabetes. Qual Life Res 17:10 (2008), 1277–1284.
39. 39 Singapore National Eye Center Finance Department, 2015.
40. 40 Singhealth Polyclinics Finance Department, 2015.
41. 41 Briggs, A., Sculpher, M., Claxton, K., Decision Modelling for Health Economic Evaluation. 2006, Oxford University Press, New York.